Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1614 1615 3785
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19349368 | HIGH SURFACE-AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS | Non-Final OA | Quetzal Therapeutics, LLC |
| 18408664 | High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients | Non-Final OA | Quetzal Therapeutics, LLC |
| 18265749 | USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES | Final Rejection | L'Oreal |
| 18284812 | IMMUNE PREPARATION, COMPOSITION COMPRISING IMMUNE PREPARATION AND USE THEREOF, AND PREPARATION METHOD | Non-Final OA | Huazhong University of Science and Technology |
| 17420589 | FLUORAPATITE-CONTAINING STRUCTURES STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH | Final Rejection | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 18567479 | FINE SILICON PARTICLE-CONTAINING PREVENTIVE OR THERAPEUTIC AGENT FOR DISEASES | Non-Final OA | Osaka University |
| 18221943 | Therapeutic Foot Patch For Cough Treatment | Non-Final OA | ASO LLC |
| 17913033 | TAF1 INHIBITORS | Non-Final OA | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18250121 | COPOLYMER CONTAINING POLY(ETHYLENE GLYCOL) AND POLY(L-AMINO ACID DERIVATIVE), MICROPARTICLES THEREOF AND USE THEREOF IN PHARMACEUTICAL COMPOSITION | Final Rejection | University of Tsukuba |
| 17997414 | THREE-DIMENSIONALLY PRINTABLE ANTIVIRAL FILAMENT | Final Rejection | Stratasys, Inc, |
| 18720104 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER OR INFLAMMATORY DISEASE | Non-Final OA | ENTEROBIOME INC. |
| 17997674 | REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF | Final Rejection | FIGENE, LLC |
| 18277898 | SELF-SUPPORTING VISCIN FILMS AND SCAFFOLDS, USES THEREOF AND METHODS FOR PREPARING THE SAME | Final Rejection | Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e. V. |
| 18411292 | METHODS AND COMPOSITIONS FOR INCREASING THE EFFECTIVENESS OF ANTIVIRAL AGENTS | Non-Final OA | ANTIVIRUS THERAPEUTICS |
| 18384195 | Gummy Configuration | Non-Final OA | ELEVATED TECH LLC |
| 18042679 | Silybum marianum (L.) Gaertn. oil for reinforcing the barrier function of the skin | Final Rejection | PIERRE FABRE DERMO-COSMETIQUE |
| 18224561 | NANOFIBER SHEET FOR HEALING TEAR OF ROTATOR CUFF CONTAINING RECOMBINANT PARATHYROID HORMONE AND METHOD FOR MANUFACTURING THE SAME | Non-Final OA | Pusan National University Industry-University Cooperation Foundation |
| 18260222 | Formulations of a Prophylactic Nasal Spray and Methods of Use and Manufacture Thereof | Non-Final OA | NTBY Moss LLC |
| 18345877 | COMPOSITION FOR ELIMINATING ODOR | Final Rejection | Thnktnk LLC (Delaware) |
| 18268786 | IN SITU SOLIDIFYING INJECTABLE COMPOSITIONS WITH TRANSIENT CONTRAST AGENTS AND METHODS OF MAKING AND USING THEREOF | Final Rejection | FLUIDX MEDICAL TECHNOLOGY, INC. |
| 18256733 | Apremilast Ophthalmic Compositions | Final Rejection | APRAMITHA INNOVATIONS PRIVATE LIMITED |
| 18037637 | TAMPON CONTAINING A PHARMACEUTICAL COMPOSITION | Non-Final OA | Swiss-Canna Group AG |
| 18199117 | HARD CAPSULE DOSAGE FORM AND USES THEREOF | Non-Final OA | EIRGEN PHARMA LTD. |
| 18005946 | HARD CAPSULE DOSAGE FORM AND USES THEREOF | Non-Final OA | EIRGEN PHARMA LTD. |
| 18252873 | Cystamine Formulations and Uses Thereof | Final Rejection | Birch Therapeutics, Inc. |
| 18248469 | ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD | Final Rejection | ACENET INC. |
| 18017133 | ECTOPARASITICIDE VETERINARY COMPOSITION | Final Rejection | HAYNE LANE LTD |
| 17614107 | PHARMACEUTICAL AGENT, MEDICINAL SOLUTION FOR CLEANING PULMONARY ALVEOLI, AND NEBULIZER | Non-Final OA | Makiko OHKIDO |
| 17198629 | COMPOSITIONS AND METHODS FOR APPLICATION OVER SKIN | Final Rejection | Shiseido Company, Limited |
| 16220387 | NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITION | Final Rejection | Modoral Brands Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy